Current status and indications for adjuvant therapy in breast cancer H. J. Senn Review Pages: 139 - 150
Pharmacokinetic approach to the selection of dose schedules for medroxyprogesterone acetate in clinical oncology V. TamassiaA. BattagliaG. Robustelli Della Cuna Original Articles Pages: 151 - 156
Antitumor activity of mitoxantrone against murine experimental tumors: Comparative analysis against various antitumor antibiotics S. FujimotoM. Ogawa Original Articles Pages: 157 - 162
Establishment of vincristine-resistant and vindesine-resistant lines of murine lymphoblasts in vitro and characterisation of their patterns of cross-resistance and drug sensitivities Bridget T. HillRichard D. H. Whelan Original Articles Pages: 163 - 169
Dibromodulcitol plus bleomycin compared with bleomycin alone in head and neck cancer B. F. IssellG. BorsosS. Eckhardt Original Articles Pages: 171 - 173
In vitro degradation of l-phenylalanine mustard (l-PAM) Thomas L. EvansSai Y. ChangKlaus Brendel Original Articles Pages: 175 - 178
Mitoxantrone: A phase II study in the treatment of patients with advanced breast carcinoma and other solid tumours R. C. Stuart-HarrisI. E. Smith Original Articles Pages: 179 - 182
Reduction of lethal toxicity of chloroethylnitrosoureas by sugar alcohols without loss of antitumor activity Tazuko TashiroMakoto InabaYoshio Sakurai Original Articles Pages: 183 - 188
Pharmacokinetics of mitomycin C in rabbit and human Guy A. van HazelJohn S. Kovach Original Articles Pages: 189 - 192
Accumulation and metabolism of new anthracycline derivatives in the heart after IV injection into mice D. Deprez-de CampeneereR. BaurainA. Trouet Original Articles Pages: 193 - 197
Phase II evaluation and plasma pharmacokinetics of high-dose intravenous 6-thioguanine in patients with colorectal carcinoma Philip H. KonitsMerrill J. EgorinPeter H. Wiernik Original Articles Pages: 199 - 203
Relationship of the duration of the chronic phase in chronic granulocytic leukaemia to the need for treatment during the first year after diagnosis Nicholas J. WarehamStephen A. JohnsonJohn M. Goldman Original Articles Pages: 205 - 210
Can severe vincristine neurotoxicity be prevented? Z. R. DesaiH. W. Van den BergR. G. Shanks Original Articles Pages: 211 - 214
The pharmacokinetics of vincristine in man: H. W. Van den BergZ. R. DesaiR. G. Shanks Original Articles Pages: 215 - 219
Renal handling of 2′-deoxyadenosine and adenosine in humans and mice John F. Kuttesch JrJ. Arly Nelson Original Articles Pages: 221 - 229
The treatment of disseminated non-Hodgkin's lymphoma of unfavourable histology C. J. GallagherA. CopplestoneT. A. Lister Original Articles Pages: 237 - 241
Cellular pharmacokinetics of aclacinomycin A in cultured L1210 cells A. ZeneberghR. BaurainA. Trouet Original Articles Pages: 243 - 249
Razoxane penetration into the cerebrospinal fluid of rats Nigel GreigFu Xiao-ChangKurt Hellmann Short Communication Pages: 251 - 252
Syndrome of inappropriate ADH secretion secondary to vinblastine Rolf A. StahelOswald Oelz Letter to the Editor Pages: 253 - 254